Zhejiang Huakang Pharmaceutical Co Ltd (605077) — Cash Flow-to-Debt Ratio
Zhejiang Huakang Pharmaceutical Co Ltd (605077) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2024, meaning its operating cash flow of CN¥146.50 Million could theoretically repay 0% of its total liabilities (CN¥3.74 Billion) in one year. See financial agility of Zhejiang Huakang Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Huakang Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Zhejiang Huakang Pharmaceutical Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see 605077 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Zhejiang Huakang Pharmaceutical Co Ltd (2016–2024)
Year-by-year debt coverage analysis for Zhejiang Huakang Pharmaceutical Co Ltd. Check Zhejiang Huakang Pharmaceutical Co Ltd (605077) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.04x | CN¥146.50 Million | CN¥3.74 Billion | ▼ -80.5% |
| 2023 | 0.20x | CN¥619.47 Million | CN¥3.08 Billion | ▼ -7.5% |
| 2022 | 0.22x | CN¥271.98 Million | CN¥1.25 Billion | ▼ -53.1% |
| 2021 | 0.46x | CN¥264.32 Million | CN¥569.56 Million | ▼ -32.1% |
| 2020 | 0.68x | CN¥335.24 Million | CN¥490.16 Million | ▲ +14.1% |
| 2019 | 0.60x | CN¥281.31 Million | CN¥469.20 Million | ▲ +158.3% |
| 2018 | 0.23x | CN¥140.97 Million | CN¥607.22 Million | ▲ +48.2% |
| 2017 | 0.16x | CN¥80.56 Million | CN¥514.17 Million | ▼ -8.0% |
| 2016 | 0.17x | CN¥93.02 Million | CN¥546.03 Million | — |